| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |